Companies similar to LongBio Pharma (Suzhou) Co., Ltd. (1779.HK)

Publicly traded Hong Kong-listed health care peers of LongBio Pharma (Suzhou) Co., Ltd., grouped by sector and comparable size.

Alphamab Oncology9966.HK
Biotechnology$1.05BCompare with 1779.HK →
—
Adlai Nortye Group Ltd.ANL
Biotechnology$1.01BCompare with 1779.HK →
—
Lepu Biopharma Co., Ltd.2157.HK
Biotechnology$982.2MCompare with 1779.HK →
—
Ascletis Pharma Inc.1672.HK
Biotechnology$1.13BCompare with 1779.HK →
—
CARsgen Therapeutics Holdings Limited2171.HK
Biotechnology$922.9MCompare with 1779.HK →
—
Mabwell (Shanghai) Bioscience Co., Ltd.2493.HK
Biotechnology$1.19BCompare with 1779.HK →
—

← Back to LongBio Pharma (Suzhou) Co., Ltd. (1779.HK)All Health Care stocks →